Principal Ingestigators
Peggy C. Nopoulos, MD
Dr. Peggy Nopoulos is a psychiatrist, the chair of the UI Department of Psychiatry, and the Principal Investigator (PI) of the UI Psychedelics Research Program's current study, "Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy (KAP) in the Treatment of Alcohol Use Disorder".
Michael Flaum, MD
Dr. Michael Flaum is a psychiatrist in the UI Department of Psychiatry. He is also the Co-Principal Investigator of the UI Psychedelics Research Program's current study.
Mark Niciu, MD, PhD
Dr. Mark Niciu is an Assistant Professor of Psychiatry in the UI Department of Psychiatry. Specializing in es-ketamine research, he is also the Co-Principal Investigator of the UI Psychedelics Research Program's current study.
Allister Wilton, MD
Dr. Allister Wilton is a psychiatrist and addiction specialist in the UI Department of Psychiatry. He is also the Co-Principal Investigator of the UI Psychedelics Research Program's current study.
Amanda Mostek, MD, PhD
Amanda Mostek is a psychiatrist and neuroscientist in the Department of Psychiatry and a member of the UI Psychedelics Research Program. Her research focus is understanding sex differences in psychedelic medications for the treatment of neuropsychiatric disorders.
Psychedelic Therapists
Annie Ventullo, LISW
Annie Ventullo is a social worker and clinical therapist who is trained as a provider of psychedelic-assisted psychotherapy (PAP).
Rebecca Stinson, PhD
Dr. Rebecca Stinson is a psychologist and clinical therapist who is trained as a provider of psychedelic assisted psychotherapy (PAP).
Administrative Staff
Erin Golden
Erin Golden is the research program coordinator for the UI Psychedelics Research Program.
Lindsey Fuhrmeister
Lindsey Fuhrmeister is the Regulatory Expert for the UI Psychedelics Research Program.